Comparison of extended flow nitric oxide parameters in smokers and non-smokers with asthma before and after an oral corticosteroid trial

M. Spears, C. Weir, J. Thompson, M. Brannigan, J. Lafferty, R. Chadhuri, G. Braganza, E. Cameron, N. Thomson (Glasgow, United Kingdom)

Source: Annual Congress 2009 - Aspects of clinical asthma
Session: Aspects of clinical asthma
Session type: Thematic Poster Session
Number: 1975
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Spears, C. Weir, J. Thompson, M. Brannigan, J. Lafferty, R. Chadhuri, G. Braganza, E. Cameron, N. Thomson (Glasgow, United Kingdom). Comparison of extended flow nitric oxide parameters in smokers and non-smokers with asthma before and after an oral corticosteroid trial. Eur Respir J 2009; 34: Suppl. 53, 1975

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008

The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012

In current smokers fraction of exhaled nitric oxide is not associated with asthma symptoms
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010

Comparison of long-acting inhaled beta2–agonists plus inhaled steroids versus increasing dose of inhaled steroids on exhaled nitric oxide among asthmatic children poorly controlled
Source: Eur Respir J 2005; 26: Suppl. 49, 617s
Year: 2005

Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study
Source: Eur Respir J 2014; 44: 1705-1707
Year: 2014


Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007


Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS)
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 259s
Year: 2004

The relationship between exhaled nitric oxide measurements and subsequent asthma control in a cohort of children followed over 12-months
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011


Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002



Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002



Influence of fluticasone propionate on levels of exhaled nitric oxide in asthmatic children: a dose response study
Source: Eur Respir J 2001; 18: Suppl. 33, 40s
Year: 2001

Association of childhood asthma and smoking with FEV1, bronchial reactivity and exhaled nitric oxide in young men with current symptomatic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 681s
Year: 2004

Measurement of exhaled nitric oxide can not reliably predict exacerbations in school-aged asthmatic children using inhaled corticosteroids
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009


FeNO (fractional exhaled nitric oxide) measurements in pregnant asthmatic women. The long-term, intra-subject variability of FeNO in controlled asthma
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012


Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma?
Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019
Year: 2020



Tapering oral corticosteroids in severe asthma is associated with a decrease in fractional exhaled nitric oxide
Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Year: 2011

Effect of cigarette smoke exposure on exhaled nitric oxide and its relation to asthma and hay feverin adult NHANES subjects
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015